Schedule 13D ownership disclosure
Bellerophon Therapeutics, Inc.
Security class unavailable · CUSIP: 078771102
Event date: 2017-09-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 8,298,755
- Percent of class
- 15.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001718111-17-000001
- Form type
- SC 13D
- Filer
- Puissance Cross-Border Opportunities III LLC
- CIK
- CIK 1718111
- Filed
- Oct 04, 2017
- Reporting period
- Sep 29, 2017
- Description
- Schedule 13D beneficial ownership